{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:46:03Z","timestamp":1792802763000,"version":"4.5.0"},"reference-count":42,"publisher":"China Science Publishing & Media Ltd.","issue":"8","license":[{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570190"],"award-info":[{"award-number":["81570190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81529001"],"award-info":[{"award-number":["81529001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670194"],"award-info":[{"award-number":["81670194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603270"],"award-info":[{"award-number":["81603270"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1093\/abbs\/gmy070","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T19:09:29Z","timestamp":1527620969000},"page":"782-792","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":27,"title":["Targeting the PI3K\/Akt\/mTOR signaling pathway by pterostilbene attenuates mantle cell lymphoma progression"],"prefix":"10.3724","volume":"50","author":[{"given":"Dandan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gege","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaikang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangning","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingcong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaomei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujing","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2018,6,29]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/CCO.0b013e32833d58f2","volume":"22","author":"Diefenbach CS","year":"2010","unstructured":"Diefenbach CS, O\u2019Connor OA. Mantle cell lymphoma in relapse: the role of emerging new drugs. Curr Opin Oncol, 2010, 22: 419-423.","journal-title":"Curr Opin Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2009-02-179739","volume":"114","author":"Ghielmini M","year":"2009","unstructured":"Ghielmini M, Zucca E. How I treat mantle cell lymphoma. Blood, 2009, 114: 1469-1476.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1158\/1078-0432.CCR-11-3152","volume":"18","author":"Deng C","year":"2012","unstructured":"Deng C, Lee S, O\u2019Connor OA. New strategies in the treatment of mantle cell lymphoma. Clin Cancer Res, 2012, 18: 3499-3508.","journal-title":"Clin Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","volume":"27","author":"Herrmann A","year":"2009","unstructured":"Herrmann A, Hoster E, Zwingers T, Brittinger G, Engelhard M, Meusers P, Reiser M. Improvement of overall survival in advanced stage mantle cell lymphoma. J Clin Oncol, 2009, 27: 511-518.","journal-title":"J Clin Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/annonc\/mdn045","volume":"19","author":"Martin P","year":"2008","unstructured":"Martin P, Chadburn A, Christos P, Furman R, Ruan J, Joyce MA, Fusco E. Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies. Ann Oncol, 2008, 19: 1327-1330.","journal-title":"Ann Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jphotobiol.2012.04.013","volume":"113","author":"Boyer JZ","year":"2012","unstructured":"Boyer JZ, Jandova J, Janda J, Vleugels FR, Elliott DA, Sligh JE. Resveratrol-sensitized UVA induced apoptosis in human keratinocytes through mitochondrial oxidative stress and pore opening. J Photochem Photobiol B, 2012, 113: 42-50.","journal-title":"J Photochem Photobiol B"},{"key":"null","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/mnfr.201000067","volume":"54","author":"Chen RJ","year":"2010","unstructured":"Chen RJ, Ho CT, Wang YJ. Pterostilbene induces autophagy and apoptosis in sensitive and chemoresistant human bladder cancer cells. Mol Nutr Food Res, 2010, 54: 1819-1832.","journal-title":"Mol Nutr Food Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ptr.2277","volume":"22","author":"Remsberg CM","year":"2008","unstructured":"Remsberg CM, Yanez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM. Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother Res, 2008, 22: 169-179.","journal-title":"Phytother Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"E1927","DOI":"10.3390\/ijms17111927","volume":"17","author":"Xie B","year":"2016","unstructured":"Xie B, Xu Z, Hu L, Chen G, Wei R, Yang G, Li B. Pterostilbene inhibits human multiple myeloma cells via ERK1\/2 and JNK pathway in vitro and in vivo. Int J Mol Sci, 2016, 17:","journal-title":"Int J Mol Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/bmc.1254","volume":"23","author":"Lin HS","year":"2009","unstructured":"Lin HS, Yue BD, Ho PC. Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomed Chromatogr, 2009, 23: 1308-1315.","journal-title":"Biomed Chromatogr"},{"key":"null","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00280-010-1525-4","volume":"68","author":"Kapetanovic IM","year":"2011","unstructured":"Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol, 2011, 68: 593-601.","journal-title":"Cancer Chemother Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jss.2009.07.027","volume":"161","author":"Alosi JA","year":"2010","unstructured":"Alosi JA, McDonald DE, Schneider JS, Privette AR, McFadden DW. Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis. J Surg Res, 2010, 161: 195-201.","journal-title":"J Surg Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/cam4.1209","volume":"6","author":"Butt NA","year":"2017","unstructured":"Butt NA, Kumar A, Dhar S, Rimando AM, Akhtar I, Hancock JC, Lage JM. Targeting MTA1\/HIF-1alpha signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression. Cancer Med, 2017, 6: 2673-2685.","journal-title":"Cancer Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1021\/tx5001392","volume":"27","author":"Suganya N","year":"2014","unstructured":"Suganya N, Bhakkiyalakshmi E, Subin TS, Krishnamurthi K, Devi SS, Lau K, Sekar TV. Proteomic identification of pterostilbene-mediated anticancer activities in HepG2 cells. Chem Res Toxicol, 2014, 27: 1243-1252.","journal-title":"Chem Res Toxicol"},{"key":"null","doi-asserted-by":"crossref","first-page":"15239","DOI":"10.1038\/srep15239","volume":"5","author":"Tolba MF","year":"2015","unstructured":"Tolba MF, Abdel-Rahman SZ. Pterostilbine, an active component of blueberries, sensitizes colon cancer cells to 5-fluorouracil cytotoxicity. Sci Rep, 2015, 5:","journal-title":"Sci Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"37417","DOI":"10.1038\/srep37417","volume":"6","author":"Kong Y","year":"2016","unstructured":"Kong Y, Chen G, Xu Z, Yang G, Li B, Wu X, Xiao W. Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells. Sci Rep, 2016, 6:","journal-title":"Sci Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2131\/jts.37.13","volume":"37","author":"Roslie H","year":"2012","unstructured":"Roslie H, Chan KM, Rajab NF, Velu SS, Kadir SA, Bunyamin I, Weber JF. 3,5-dibenzyloxy-4\u2019-hydroxystilbene induces early caspase-9 activation during apoptosis in human K562 chronic myelogenous leukemia cells. J Toxicol Sci, 2012, 37: 13-21.","journal-title":"J Toxicol Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00280-005-0111-7","volume":"57","author":"Kim R","year":"2006","unstructured":"Kim R, Emi M, Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol, 2006, 57: 545-553.","journal-title":"Cancer Chemother Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"18469","DOI":"10.18632\/oncotarget.7841","volume":"7","author":"Dhar S","year":"2016","unstructured":"Dhar S, Kumar A, Zhang L, Rimando AM, Lage JM, Lewin JR, Atfi A. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget, 2016, 7: 18469-18484.","journal-title":"Oncotarget"},{"key":"null","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1021\/jf301499e","volume":"60","author":"Lin VC","year":"2012","unstructured":"Lin VC, Tsai YC, Lin JN, Fan LL, Pan MH, Ho CT, Wu JY. Activation of AMPK by pterostilbene suppresses lipogenesis and cell-cycle progression in p53 positive and negative human prostate cancer cells. J Argric Food Chem, 2012, 60: 6399-6407.","journal-title":"J Argric Food Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s11605-012-1869-7","volume":"16","author":"McCormack DE","year":"2012","unstructured":"McCormack DE, Mannal P, McDonald D, Tighe S, Hanson J, McFadden D. Genomic analysis of pterostilbene predicts its antiproliferative effects against pancreatic cancer in vitro and in vivo. J Gastrointest Surg, 2012, 16: 1136-1143.","journal-title":"J Gastrointest Surg"},{"key":"null","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/1940-6207.CAPR-08-0224","volume":"2","author":"Paul S","year":"2009","unstructured":"Paul S, Rimando AM, Lee HJ, Ji Y, Reddy BS, Suh N. Anti-inflammatory action of pterostilbene is mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells. Cancer Prev Res (Phila), 2009, 2: 650-657.","journal-title":"Cancer Prev Res (Phila)"},{"key":"null","first-page":"44","volume":"4","author":"Wang Y","year":"2012","unstructured":"Wang Y, Ding L, Wang X, Zhang J, Han W, Feng L, Sun J. Pterostilbene simultaneously induces apoptosis, cell cycle arrest and cyto-protective autophagy in breast cancer cells. Am J Transl Res, 2012, 4: 44-51.","journal-title":"Am J Transl Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/carcin\/bgp121","volume":"30","author":"Pan MH","year":"2009","unstructured":"Pan MH, Chiou YS, Chen WJ, Wang JM, Badmaev V, Ho CT. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Carcinogenesis, 2009, 30: 1234-1242.","journal-title":"Carcinogenesis"},{"key":"null","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1002\/pmic.200800080","volume":"8","author":"Cecconi D","year":"2008","unstructured":"Cecconi D, Zamo A, Bianchi E, Parisi A, Barbi S, Milli A, Rinalducci S. Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study. Proteomics, 2008, 8: 4495-4506.","journal-title":"Proteomics"},{"key":"null","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1182\/blood-2007-07-103481","volume":"111","author":"Dal Col J","year":"2008","unstructured":"Dal Col J, Zancai P, Terrin L, Guidoboni M, Ponzoni M, Pavan A, Spina M. Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma. Blood, 2008, 111: 5142-5151.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","volume":"130","author":"Rizzatti EG","year":"2005","unstructured":"Rizzatti EG, Falcao RP, Panepucci RA, Proto-Siqueira R, Anselmo-Lima WT, Okamoto OK, Zago MA. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. Br J Haematol, 2005, 130: 516-526.","journal-title":"Br J Haematol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","volume":"108","author":"Rudelius M","year":"2006","unstructured":"Rudelius M, Pittaluga S, Nishizuka S, Pham TH, Fend F, Jaffe ES, Quintanilla-Martinez L. Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood, 2006, 108: 1668-1676.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/abbs\/gmw110","volume":"48","author":"Xie B","year":"2016","unstructured":"Xie B, Xu Z, Yang G, Chen G, Li B, Hu L, Xiao W. Antitumor effect of dobutamine on multiple myeloma via mitogen-activated protein kinase pathway in vitro. Acta Biochim Biophys Sin (Shanghai), 2016, 48: 1135-1137.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"null","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbrc.2016.06.108","volume":"478","author":"Yue J","year":"2016","unstructured":"Yue J, Jin S, Li Y, Zhang L, Jiang W, Yang C, Du J. Magnesium inhibits the calcification of the extracellular matrix in tendon-derived stem cells via the ATP-P2R and mitochondrial pathways. Biochem Biophys Res Commun, 2016, 478: 314-322.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2016.07.046","volume":"789","author":"Kosuru R","year":"2016","unstructured":"Kosuru R, Rai U, Prakash S, Singh A, Singh S. Promising therapeutic potential of pterostilbene and its mechanistic insight based on preclinical evidence. Eur J Pharmacol, 2016, 789: 229-243.","journal-title":"Eur J Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"Cantley LC","year":"2002","unstructured":"Cantley LC. The phosphoinositide 3-kinase pathway. Science, 2002, 296: 1655-1657.","journal-title":"Science"},{"key":"null","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1080\/10428190500159944","volume":"46","author":"Fillmore GC","year":"2005","unstructured":"Fillmore GC, Wang Q, Carey MJ, Kim CH, Elenitoba-Johnson KS, Lim MS. Expression of Akt (protein kinase B) and its isoforms in malignant lymphomas. Leuk Lymphoma, 2005, 46: 1765-1773.","journal-title":"Leuk Lymphoma"},{"key":"null","first-page":"461487","volume":"2013","author":"Lv H","year":"2013","unstructured":"Lv H, Li Y, Du H, Fang J, Song X, Zhang J. The synthetic compound norcantharidin induced apoptosis in mantle cell lymphoma in vivo and in vitro through the PI3K-Akt-NF- kappa B signaling pathway. Evid Based Complement Alternat Med, 2013, 2013:","journal-title":"Evid Based Complement Alternat Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","volume":"9","author":"Song G","year":"2005","unstructured":"Song G, Ouyang G, Bao S. The activation of Akt\/PKB signaling pathway and cell survival. J Cell Mol Med, 2005, 9: 59-71.","journal-title":"J Cell Mol Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1182\/blood.V98.3.787","volume":"98","author":"Hofmann WK","year":"2001","unstructured":"Hofmann WK, de Vos S, Tsukasaki K, Wachsman W, Pinkus GS, Said JW, Koeffler HP. Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood, 2001, 98: 787-794.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","volume":"7","author":"Jares P","year":"2007","unstructured":"Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer, 2007, 7: 750-762.","journal-title":"Nat Rev Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","volume":"117","author":"Perez-Galan P","year":"2011","unstructured":"Perez-Galan P, Dreyling M, Wiestner A. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood, 2011, 117: 26-38.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.leukres.2012.02.010","volume":"36","author":"Kim A","year":"2012","unstructured":"Kim A, Park S, Lee JE, Jang WS, Lee SJ, Kang HJ, Lee SS. The dual PI3K and mTOR inhibitor NVP-BEZ235 exhibits anti-proliferative activity and overcomes bortezomib resistance in mantle cell lymphoma cells. Leuk Res, 2012, 36: 912-920.","journal-title":"Leuk Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"38225","DOI":"10.18632\/oncotarget.5425","volume":"6","author":"Kim A","year":"2015","unstructured":"Kim A, Seong KM, Kang HJ, Park S, Lee SS. Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance. Oncotarget, 2015, 6: 38225-38238.","journal-title":"Oncotarget"},{"key":"null","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1182\/blood-2009-10-251082","volume":"115","author":"Bhatt AP","year":"2010","unstructured":"Bhatt AP, Bhende PM, Sin SH, Roy D, Dittmer DP, Damania B. Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K\/Akt\/mTOR-addicted lymphomas. Blood, 2010, 115: 4455-4463.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/abbs\/gmx108","volume":"49","author":"Liu Y","year":"2017","unstructured":"Liu Y, Duan L, Tian J, Song D, Zhang M, Zhao S, Yin Z. Role of the Akt\/mTOR signaling pathway in human papillomavirus-associated nasal and sinonasal inverted papilloma. Acta Biochim Biophys Sin (Shanghai), 2017, 49: 1067-1074.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/BBA47557932C408BBA13457A8926F6C3","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmy070","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/BBA47557932C408BBA13457A8926F6C3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T15:41:33Z","timestamp":1661355693000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmy070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,6,29]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmy070","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}